Atlas Trials

DN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial Carcinoma

Clinical trial NCT01353222 · TERMINATED

Trial details

NCT number
NCT01353222
Sponsor
Dendreon
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Urothelial Carcinoma
Start date
2011-06-01
Primary completion
2015-07-01
Enrollment
142

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.